Crizotinib/doxorubicin liposomal/ifosfamideVarious toxicities: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2018年 / 1720卷 / 1期

关键词：

D O I：

10.1007/s40278-018-51879-z

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：85 / 85

相关论文

共 50 条

[31] Crizotinib/dexamethasoneVarious toxicities: case report
Reactions Weekly, 2022, 1913 (1) : 168 - 168
[32] Doxorubicin-liposomal/paclitaxel/pomalidomideVarious toxicities and lack of efficacy: case report
Reactions Weekly, 2021, 1851 (1) : 139 - 139
[33] IfosfamideVarious toxicities including peripheral nerve disorders: case report
Reactions Weekly, 2002, 888 (1) : 9 - 9
[34] Crizotinib/Nedaplatin/PemetrexedVarious toxicities: case report
Reactions Weekly, 2025, 2049 (1) : 121 - 121
[35] Crizotinib/everolimus interactionVarious toxicities: case report
Reactions Weekly, 2020, 1822 (1) : 105 - 105
[36] Crizotinib/enoxaparin sodiumVarious toxicities: case report
Reactions Weekly, 2012, 1394 (1) : 17 - 17
[37] IfosfamideVarious toxicities: 2 case reports
Reactions Weekly, 2015, 1565 (1) : 135 - 135
[38] Nail toxicities induced by liposomal doxorubicin: a retrospective case series
Mario Vaccaro
Mariacarmela Santarpia
Francesco Borgia
Roberta Giuffrida
Giuseppe Altavilla
Bianca Maria Piraccini
Serafinella Patrizia Cannavò
European Journal of Dermatology, 2017, 27 : 434 - 435
[39] Nail toxicities induced by liposomal doxorubicin: a retrospective case series
Vaccaro, Mario
Santarpia, Mariacarmela
Borgia, Francesco
Giuffrida, Roberta
Altavilla, Giuseppe
Piraccini, Bianca Maria
Cannavo, Serafinella Patrizia
EUROPEAN JOURNAL OF DERMATOLOGY, 2017, 27 (04) : 434 - 435
[40] Antineoplastics/ifosfamideVarious toxicities: 4 case reports
Reactions Weekly, 2022, 1919 (1) : 88 - 88

← 1 2 3 4 5 →